Cytogenetic studies in 45 patients with acute lymphocytic leukemia

J. Whang-Peng, E. J. Freireich, J. J. Oppenheim, E. Frei, J. H. Tjio

研究成果: 雜誌貢獻文章

42 引文 (Scopus)

摘要

The chromosomes of bone marrow and peripheral blood were studied in 45 unselected patients with acute lymphocytic leukemia. Eighteen had no detectable chromosome abnormality in either leukemic or somatic cells. Five of these had detectable Philadelphia chromosome-positive cells after receiving leukocyte transfusions from chronic myelocytic leukemia donors. Six others, who had no abnormalities of their cells, were studied only in remission. Three patients had congenital cytogenetic abnormalities. Five had a wide range of chromosome distribution associated with intensive chemotherapy. These chromosome abnormalities readily reverted in 2 of these 5 patients with cessation of therapy. Thirteen subjects had cytogenetic abnormalities in their leukemic cells. These consisted of aneuploid cell lines found more frequently during the final 2 months of the patient's life than during the initial 6 weeks of illness. In these individuals, there was no apparent relationship between chromosome abnormalities and therapy. Once these abnormalities appeared, they tended to persist. None of these patients had the same chromosomal abnormalities; therefore, no unique chromosomal abnormalities were found in acute lymphocytic leukemia. These aneuploid cell lines probably represent selected outgrowth of abnormal cells during the disease. In all our patients, including those on intensive chemotherapy, the incidence of minor and major chromosome aberrations was not significant.
原文英語
頁(從 - 到)881-897
頁數17
期刊Journal of the National Cancer Institute
42
發行號6
DOIs
出版狀態已發佈 - 一月 1 1969
對外發佈Yes

指紋

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cytogenetics
Chromosome Aberrations
Aneuploidy
Leukocyte Transfusion
Chromosomes
Drug Therapy
Cell Line
Philadelphia Chromosome
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Bone Marrow
Tissue Donors
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

引用此文

Cytogenetic studies in 45 patients with acute lymphocytic leukemia. / Whang-Peng, J.; Freireich, E. J.; Oppenheim, J. J.; Frei, E.; Tjio, J. H.

於: Journal of the National Cancer Institute, 卷 42, 編號 6, 01.01.1969, p. 881-897.

研究成果: 雜誌貢獻文章

Whang-Peng, J. ; Freireich, E. J. ; Oppenheim, J. J. ; Frei, E. ; Tjio, J. H. / Cytogenetic studies in 45 patients with acute lymphocytic leukemia. 於: Journal of the National Cancer Institute. 1969 ; 卷 42, 編號 6. 頁 881-897.
@article{56d6d0367eca41dabe65eef3a493aee4,
title = "Cytogenetic studies in 45 patients with acute lymphocytic leukemia",
abstract = "The chromosomes of bone marrow and peripheral blood were studied in 45 unselected patients with acute lymphocytic leukemia. Eighteen had no detectable chromosome abnormality in either leukemic or somatic cells. Five of these had detectable Philadelphia chromosome-positive cells after receiving leukocyte transfusions from chronic myelocytic leukemia donors. Six others, who had no abnormalities of their cells, were studied only in remission. Three patients had congenital cytogenetic abnormalities. Five had a wide range of chromosome distribution associated with intensive chemotherapy. These chromosome abnormalities readily reverted in 2 of these 5 patients with cessation of therapy. Thirteen subjects had cytogenetic abnormalities in their leukemic cells. These consisted of aneuploid cell lines found more frequently during the final 2 months of the patient's life than during the initial 6 weeks of illness. In these individuals, there was no apparent relationship between chromosome abnormalities and therapy. Once these abnormalities appeared, they tended to persist. None of these patients had the same chromosomal abnormalities; therefore, no unique chromosomal abnormalities were found in acute lymphocytic leukemia. These aneuploid cell lines probably represent selected outgrowth of abnormal cells during the disease. In all our patients, including those on intensive chemotherapy, the incidence of minor and major chromosome aberrations was not significant.",
author = "J. Whang-Peng and Freireich, {E. J.} and Oppenheim, {J. J.} and E. Frei and Tjio, {J. H.}",
year = "1969",
month = "1",
day = "1",
doi = "10.1093/jnci/42.6.881",
language = "English",
volume = "42",
pages = "881--897",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Cytogenetic studies in 45 patients with acute lymphocytic leukemia

AU - Whang-Peng, J.

AU - Freireich, E. J.

AU - Oppenheim, J. J.

AU - Frei, E.

AU - Tjio, J. H.

PY - 1969/1/1

Y1 - 1969/1/1

N2 - The chromosomes of bone marrow and peripheral blood were studied in 45 unselected patients with acute lymphocytic leukemia. Eighteen had no detectable chromosome abnormality in either leukemic or somatic cells. Five of these had detectable Philadelphia chromosome-positive cells after receiving leukocyte transfusions from chronic myelocytic leukemia donors. Six others, who had no abnormalities of their cells, were studied only in remission. Three patients had congenital cytogenetic abnormalities. Five had a wide range of chromosome distribution associated with intensive chemotherapy. These chromosome abnormalities readily reverted in 2 of these 5 patients with cessation of therapy. Thirteen subjects had cytogenetic abnormalities in their leukemic cells. These consisted of aneuploid cell lines found more frequently during the final 2 months of the patient's life than during the initial 6 weeks of illness. In these individuals, there was no apparent relationship between chromosome abnormalities and therapy. Once these abnormalities appeared, they tended to persist. None of these patients had the same chromosomal abnormalities; therefore, no unique chromosomal abnormalities were found in acute lymphocytic leukemia. These aneuploid cell lines probably represent selected outgrowth of abnormal cells during the disease. In all our patients, including those on intensive chemotherapy, the incidence of minor and major chromosome aberrations was not significant.

AB - The chromosomes of bone marrow and peripheral blood were studied in 45 unselected patients with acute lymphocytic leukemia. Eighteen had no detectable chromosome abnormality in either leukemic or somatic cells. Five of these had detectable Philadelphia chromosome-positive cells after receiving leukocyte transfusions from chronic myelocytic leukemia donors. Six others, who had no abnormalities of their cells, were studied only in remission. Three patients had congenital cytogenetic abnormalities. Five had a wide range of chromosome distribution associated with intensive chemotherapy. These chromosome abnormalities readily reverted in 2 of these 5 patients with cessation of therapy. Thirteen subjects had cytogenetic abnormalities in their leukemic cells. These consisted of aneuploid cell lines found more frequently during the final 2 months of the patient's life than during the initial 6 weeks of illness. In these individuals, there was no apparent relationship between chromosome abnormalities and therapy. Once these abnormalities appeared, they tended to persist. None of these patients had the same chromosomal abnormalities; therefore, no unique chromosomal abnormalities were found in acute lymphocytic leukemia. These aneuploid cell lines probably represent selected outgrowth of abnormal cells during the disease. In all our patients, including those on intensive chemotherapy, the incidence of minor and major chromosome aberrations was not significant.

UR - http://www.scopus.com/inward/record.url?scp=0014528296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014528296&partnerID=8YFLogxK

U2 - 10.1093/jnci/42.6.881

DO - 10.1093/jnci/42.6.881

M3 - Article

C2 - 4240411

AN - SCOPUS:0014528296

VL - 42

SP - 881

EP - 897

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 6

ER -